Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_assertion type Assertion NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_head.
- NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_provenance.
- NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_assertion evidence source_evidence_literature NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_provenance.
- NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_assertion SIO_000772 12835728 NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_provenance.
- NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_assertion wasDerivedFrom befree-20150227 NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_provenance.
- NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_assertion wasGeneratedBy ECO_0000203 NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_provenance.